SANTA ROSA, Calif., July 1, 2025 — VisiQuate, a prominent player in AI-powered revenue cycle management (RCM), has announced its acquisition of Etyon, a healthcare technology firm renowned for its advanced RCM machine learning and data tokenization capabilities. This strategic move aims to bolster VisiQuate’s ability to transform complex healthcare data into actionable insights, addressing inefficiencies such as denials and workflow bottlenecks.
The acquisition is set to enhance VisiQuate’s platform by integrating Etyon’s predictive models and denial prevention algorithms. This integration promises to empower revenue cycle teams with real-time operational guidance, enabling them to prioritize tasks more effectively and optimize workforce productivity.
Strengthening AI and Machine Learning in Healthcare
VisiQuate’s acquisition of Etyon represents a significant step in the evolution of AI and machine learning applications in healthcare revenue management. Etyon’s technology is designed to surface actionable insights from vast amounts of data, effectively acting as a “GPS” for revenue cycle teams, according to Brian Robertson, Founder & CEO of VisiQuate.
“Etyon doesn’t just analyze data – they surface answers that are highly actionable,” Robertson stated. “Their framework shows you what’s wrong, tells you why it matters, and recommends exactly what to do next.”
“This kind of clarity amplifies and reinforces what VisiQuate’s platform has been doing for years — especially as providers navigate a minefield of denials, staffing constraints, and operational inefficiencies that demand smarter, faster decisions.”
Enhancing Real-Time Intelligence
By incorporating Etyon’s machine learning models and tokenized data structures into VisiQuate’s Ana Intelligence Suite, clients will gain access to enhanced real-time intelligence. This advancement aims to eliminate guesswork, streamline workflows, and drive higher financial yields for healthcare providers.
Derek Foster, CEO & Founder of Etyon, expressed enthusiasm about the partnership. “We’ve spent years building and refining RCM machine learning models that think like revenue cycle leaders. Now, by joining forces with VisiQuate, we’re not just scaling that expertise — we’re turbocharging it,” he said.
“This partnership gives us the platform, reach, and resources to accelerate everything we’ve built, and to deliver powerful, real-time guidance at a whole new level.”
Industry Implications and Future Prospects
The acquisition of Etyon by VisiQuate is poised to have far-reaching implications for the healthcare industry, particularly in the realm of revenue cycle management. According to Park Durrett, Managing Director at Accel-KKR, the merger adds significant value to VisiQuate’s existing capabilities.
“This acquisition adds fuel to an already powerful engine,” Durrett noted. “Etyon’s focused expertise in deep RCM modeling, tokenization, and signal delivery complements VisiQuate’s platform.”
“Whether supporting enterprise health systems or lean teams in smaller organizations, this acquisition expands VisiQuate’s ability to offer an even more scalable, precise, and actionable solution for healthcare organizations under increasing pressure to do more with less.”
About VisiQuate and Etyon
VisiQuate is committed to providing healthcare organizations with AI-driven automation, advanced analytics, and intelligent workflows to reduce inefficiencies and maximize revenue. Their solutions are designed to predict and prevent revenue cycle bottlenecks, ensuring healthcare providers can optimize their financial performance.
Founded in 2014, Etyon specializes in AI-driven Revenue Cycle Management solutions that enhance revenue per patient and streamline operational processes. Their technology is widely used across healthcare, laboratory, and business services industries.
The acquisition marks a pivotal moment for both companies, as they combine their expertise to drive innovation and efficiency in healthcare revenue management. For more information, visit visiquate.com or etyon.com.